WILMINGTON, N.C., June 3 /PRNewswire/ -- Inclinix, Inc. a contract research organization that hires physicians and recruits patients for the clinical trials of new drugs, today announced restructuring of positions to support continued growth. Inclinix previously announced a growth rate of 40% in 2007 and the infusion of $10 million in expansion funding, which came in January from Frontier Capital, a private equity firm.
Diane Montross will assume a newly created position, Director of Patient Recruitment. Diane will be responsible for strategically positioning the products and services that support clinical trial enrollment and facilitating customized solutions. Having spent the previous six years with Veritas Medicine as the Director of Media Services, Diane's expertise and industry relationships will be primarily focused toward expanding online patient recruitment and advocacy efforts.
Tobin Geatz, President and Chief Executive Officer of Inclinix, said, "We are delighted that Diane joined the company. She has years of online outreach experience for patients. Now, she will apply her expertise to make our patient outreach programs the best in the industry."
Inclinix's rapid expansion has driven several other internal promotions:
Steve Agnoff has assumed the role of Senior Vice President of Sales and Marketing. He will closely integrate the sales and marketing efforts to drive corporate expansion.
Susan Jalbert has assumed the role of Vice President of Sales. Ms. Jalbert provides strategic direction for a team of business development personnel covering the U.S. and abroad.
Bill Gwinn has assumed the role of Vice President of New Product Development. Gwinn has already led development of new tools named Critical Population Research (CPR(R)). CPR supports feasibility studies, selection of the best trial sites, and optimization of advertising to recruit patients.
Overall employment is growing with increasing sales. Inclinix will maintain its headquarters in Wilmington, NC, but will expand to larger facilities this summer.
Founded in 1999, Inclinix, Inc., is the industry's enrollment CRO. Its IQM(TM) enrollment process uses technology to identify, qualify, and manage patients for the clinical trials of new medical therapies. Clients include pharmaceutical, biotechnology and medical-device organizations. In addition, Inclinix provides strategic medical marketing communications and adherence services to the healthcare industry. For more information on Inclinix, visit http://www.inclinix.com .
|SOURCE Inclinix, Inc.|
Copyright©2008 PR Newswire.
All rights reserved